You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Boehringer Ingelheim
Medtronic
Baxter
McKinsey

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

NEOPAP Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Neopap patents expire, and when can generic versions of Neopap launch?

Neopap is a drug marketed by Polymedica and is included in one NDA.

The generic ingredient in NEOPAP is acetaminophen. There are sixty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.

US ANDA Litigation and Generic Entry Outlook for Neopap

A generic version of NEOPAP was approved as acetaminophen by PERRIGO on February 25th, 2000.

  Start Trial

Summary for NEOPAP
Drug patent expirations by year for NEOPAP

US Patents and Regulatory Information for NEOPAP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Polymedica NEOPAP acetaminophen SUPPOSITORY;RECTAL 016401-001 Approved Prior to Jan 1, 1982 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Moodys
McKesson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.